1. Is very high platelet count always associated with essential thrombocythemia? An unusual presentation in a child
   Elif Habibe Aktekin et al, 2023, Laboratory Medicine CrossRef
2. Coexisting driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients
   L. De Roeck et al, 2018, Hematology CrossRef
3. Coexistence of breakpoint cluster region-Abelson1 rearrangement and Janus kinase 2 V617F mutation in chronic myeloid leukemia: A case report
   Xue-Bing Shi et al, 2019, World Journal of Clinical Cases CrossRef
4. Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination
   Magda Zanelli et al, 2024, Frontiers in Oncology CrossRef
5. Co-existence of BCR-ABL and JAK2V617F mutation in resistant chronic myeloid leukemia in the imatinib era: Is there a correlation?
   Rim Frikha et al, 2021, Journal of Oncology Pharmacy Practice CrossRef
6. Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
   K. Lewandowski et al, 2018, International Journal of Laboratory Hematology CrossRef
7. Co‐occurrence of BCR–ABL1‐positive chronic myeloid leukaemia and CALR‐mutated essential thrombocythaemia
   Victor E. F. da Costa et al, 2020, British Journal of Haematology CrossRef
8. Concomitant presence of JAK2V617F mutation and BCR‑ABL translocation in two patients: A new entity or a variant of myeloproliferative neoplasms (Case report)
   Filipa Mousinho et al, 2018, Molecular Medicine Reports CrossRef